Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine
Abstract
Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg.
[NSAIDs] Non-steroidal anti-inflammatory drugs consider an important group of drugs due to their properties as anti-inflammatory and it have both antipyretic and pain killer activities. [COX-II] plays an important role all over oncogenesis and here we attempt the same thing to search the use of [NSAID] (Etodolac & tolmetin) in conjugation with current cytotoxic agent (Gemcitabine) for the prevention and/or management of cancer. This study distinguishes the designing and synthesis of mutual prodrug of [NSAID] & gemcitabine, which is specified to create the concomitantly pharmacological action as a one chemical entity with amend of targeting of drug. The synthesized compound was conferred by TLC, CHNS, FTIR and physicochemical properties. The newly synthesized prodrug is predicted to reduce the adverse effects of [NSAIDs] on the (GIT) gastrointestinal tract with enhancement of gemcitabine oral bioavailability and its targeting.
| How to Cite this Article |
| Pubmed Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . SRP. 2020; 11(11): 315-318. doi:10.31838/srp.2020.11.46 Web Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . http://www.sysrevpharm.org/?mno=16567 [Access: March 29, 2021]. doi:10.31838/srp.2020.11.46 AMA (American Medical Association) Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . SRP. 2020; 11(11): 315-318. doi:10.31838/srp.2020.11.46 Vancouver/ICMJE Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . SRP. (2020), [cited March 29, 2021]; 11(11): 315-318. doi:10.31838/srp.2020.11.46 Harvard Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg (2020) Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . SRP, 11 (11), 315-318. doi:10.31838/srp.2020.11.46 Turabian Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. 2020. Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . Systematic Reviews in Pharmacy, 11 (11), 315-318. doi:10.31838/srp.2020.11.46 Chicago Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. "Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine ." Systematic Reviews in Pharmacy 11 (2020), 315-318. doi:10.31838/srp.2020.11.46 MLA (The Modern Language Association) Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg. "Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine ." Systematic Reviews in Pharmacy 11.11 (2020), 315-318. Print. doi:10.31838/srp.2020.11.46 APA (American Psychological Association) Style Ammar Abdul Aziz Alibeg, Abbas H. Abdulsada, Noor H. Nasser, Karrar Abdil Aziz Ali beg (2020) Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine . Systematic Reviews in Pharmacy, 11 (11), 315-318. doi:10.31838/srp.2020.11.46 |
Abstract
PDF
How to cite this article
Related Records